Reference values for plasma dipeptidyl-peptidase IV activity and iheir association with other laboratory parameters

被引:54
作者
Durinx, C
Neels, H
Van der Auwera, JC
Naelaerts, K
Scharpé, S
De Meester, I
机构
[1] Univ Instelling Antwerp, Biochim Clin Lab, B-2610 Wilrijk, Belgium
[2] OCMW Hosp, Lab Clin Biol, Antwerp, Belgium
关键词
dipeptidyl-peptidase IV; CD26; reference values; multiple regression analysis; gender; hormone replacement therapy; contraception;
D O I
10.1515/CCLM.2001.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In blood, the exopeptidase dipeptidyl-peptidase IV (DPPIV; EC 3.4.14.5) is predominantly present in a soluble form in plasma/serum and as an activation antigen on the membrane of lymphocytes (CD26). It modifies some important biologically active peptides (neuropeptides, chemokines), and a regulatory role for DPPlV/CD26 in immune and endocrine processes has been demonstrated. The aim of this study was to determine reference values for plasma/serum DPPIV activity and to study the association of this activity with a series of biochemical and hematological parameters and baseline characteristics such as age, gender, blood pressure and body mass index. We studied 481 healthy subjects aged between 19 and 61 years. The group consisted of 213 men and 268 women equally divided between the different categories of age. Among the women, 127 were taking hormone therapy (contraception/hormone replacement) and 141 were not. A multiple regression model shows that DPPIV activity decreases significantly with age. The activity in women is slightly lower than in men. We observed an important association with liver, muscle and lipid metabolism-related parameters. In this model, no significant contribution of body mass index, blood pressure or hormone therapy could be stated.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 50 条
  • [1] Dipeptidyl-peptidase IV-β -: Further characterization and comparison to dipeptidyl-peptidase IV activity of CD26
    Blanco, J
    Nguyen, C
    Callebaut, C
    Jacotot, E
    Krust, B
    Mazaleyrat, JP
    Wakselman, M
    Hovanessian, AG
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 256 (02): : 369 - 378
  • [2] KINETICS OF DIPEPTIDYL PEPTIDASE-IV PROTEOLYSIS OF GROWTH HORMONE-RELEASING FACTOR AND ANALOGS
    BONGERS, J
    LAMBROS, T
    AHMAD, M
    HEIMER, EP
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (02) : 147 - 153
  • [3] BURCHARDT U, 1987, Z KLIN MED, V42, P245
  • [4] CD26, let it cut or cut it down
    De Meester, I
    Korom, S
    Van Damme, J
    Scharpé, S
    [J]. IMMUNOLOGY TODAY, 1999, 20 (08): : 367 - 375
  • [5] CHARACTERIZATION OF DIPEPTIDYL PEPTIDASE-IV (CD26) FROM HUMAN-LYMPHOCYTES
    DEMEESTER, I
    VANHOOF, G
    HENDRIKS, D
    DEMUTH, HU
    YARON, A
    SCHARPE, S
    [J]. CLINICA CHIMICA ACTA, 1992, 210 (1-2) : 23 - 34
  • [6] Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26 dipeptidyl peptidase IV (EC 3.4.14.5)
    DeMeester, I
    Vanhoof, G
    Lambeir, AM
    Scharpe, S
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 189 (01) : 99 - 105
  • [7] Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
    Drucker, DJ
    Shi, Q
    Crivici, A
    SumnerSmith, M
    Tavares, W
    Hill, M
    DeForest, L
    Cooper, S
    Brubaker, PL
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (07) : 673 - 677
  • [8] DukeCohan JS, 1996, J IMMUNOL, V156, P1714
  • [9] Molecular characterization of dipeptidyl peptidase activity in serum -: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
    Durinx, C
    Lambeir, AM
    Bosmans, E
    Falmagne, JB
    Berghmans, R
    Haemers, A
    Scharpé, S
    De Meester, I
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (17): : 5608 - 5613
  • [10] EGGSTEIN S, 1989, J CLIN CHEM CLIN BIO, V27, P547